By Kelly A. Briganti, Editorial Director, G2 Intelligence
Three researchers have suggested that the success of genomic testing depends on post-market data collection and analysis to help determine its safety and effectiveness. They further claim that Congressional action is needed to "incentivize the development of the massive data systems that doctors and regulators will need in order to make these tests safe and effective for…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
A new test can reveal a person's entire viral exposure history from a single drop of blood, according to a study published June 5 in Science. The VirScan test allows for simultaneous, comprehensive analysis of antiviral antibodies in human serum by combining immunoprecipitation and…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
Natera, the California-based molecular diagnostics company, said it has tweaked its Panorama prenatal test to identify so-called molar pregnancies during the first trimester.
Molar pregnancies, which occur in about one in every 1,000 pregnancies, occur when both sets of chromosomes are from the father. Such pregnancies, which almost always end in a…
Read more...
Psyche Systems Corporation is a private, profit-driven software company that has focused  exclusively on delivering laboratory information software to hospitals, clinics, reference and private labs since 1976. It is this unwavering focus on serving our core customer base that has enabled Psyche to maintain strong customer loyalty and deliver on our commitment to high quality products and services. Psyche Systems' laboratory information software are best-of-breed products designed to meet the specific needs of anatomic pathology, cytology, histology, dermatopathology, GI, clinical, toxicology, microbiology and molecular laboratories. We at Psyche work closely with our customer base during product development to ensure we are delivering the highest quality products and services at a competitive price.
By Kelly A. Briganti, Editorial Director, G2 Intelligence
A May survey of insured consumers (with self- or employer-sponsored insurance) reveals that many want to be able to monitor their health and wellness independently without getting a doctor's order for blood testing. It also reveals how little consumers know about the new options out there for blood testing. HealthMine, a consumer health engagement company, conducted the…
Read more...
By Stephanie Murg, Managing Director, G2 Intelligence
Efforts to discourage the use of high-cost, low-value preoperative tests—those ordered "in the absence of a specific clinical indication or purpose"—have had little effect on utilization, according to a national study published earlier this month in the online edition of JAMA Internal Medicine. Researchers at New York University's Langone Medical Center found that…
Read more...
|
